Skip to main content
SpringerLink
Log in

The role of the 5-HT2A and 5-HT2C receptors in the stimulus effects ofm-chlorophenylpiperazine

  • Original Investigation
  • Published:
Psychopharmacology Aims and scope Submit manuscript

Abstract

m-Chlorophenylpiperazine (mCPP), a major metabolite of the atypical antidepressant trazadone, has been observed to produce marked physiological and behavioral effects in both humans and animals. These effects have been attributed to the interaction of mCPP with serotonergic receptors. The present study was designed to characterize those interactions of mCPP with central serotonergic receptors which mediate mCPP-induced stimulus control. A series of serotonergic antagonists (mesulergine, pizotyline, ketanserin, spiperone, risperidone, ritanserin, metergoline, pirenpirone, and LY53857) was tested for the ability to block the mCPP stimulus. The affinity of these antagonists for 5-HT2A and 5-HT2C receptors was then correlated with maximal percent inhibition of the mCPP stimulus. Kd at the 5-HT2C receptor was inversely proportional (r=−0.75,P<0.05), and Kd at the 5-HT2A receptor directly proportional (r=+0.67,P<0.05) to the maximal percent inhibition of the mCPP stimulus. The 5-HT2C selectivity ratio [Kd(5-HT2A)/Kd(5-HT2C)] of the antagonists was directly proportional (r=+0.86,P<0.01) to maximal percent inhibition of the mCPP stimulus. A multiple regressions analysis indicated that 81% of the variance in the ability of a given antagonist to block the mCPP stimulus could be predicted on the basis of its affinity for 5-HT2A and 5-HT2C receptors. It is concluded that the stimulus effects of mCPP are mediated predominantly by a combination of agonist activity at 5-HT2C receptors and antagonist activity at 5-HT2A receptors.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Ator NA, Griffiths RR (1989) Asymmetrical cross-generalization in drug discrimination with lorazepam and pentobarbital training conditions. Drug Dev Res 16:355–364

    Google Scholar 

  • Bagdy G, Szemeredi K, Kenyicska B, Murphy DL (1989a) Different serotonin receptors mediate blood-pressure, heart rate, plasma catecholamine and prolactin responses tom-chlorophenylpiperazine in conscious rats. J Pharmacol Exp Ther 250:72–78

    Google Scholar 

  • Bagdy G, Calogero AE, Murphy DL, Szemeredi K (1989b) Serotonin agonists cause parallel activation of the sympathoadrenomedullary system and the hypothalamo-pituitary-adrenocortical axis in conscious rats. Endocrinology 125:2664–2669

    Google Scholar 

  • Balster RL (1990) Perception of drug effects. In: Berkeley MA, Stebbins WG (eds) Comparative perception, vol 1: basic mechanisms. Wiley, N.Y. pp 127–154

    Google Scholar 

  • Brady JV, Hienz RD, Ator NA (1990) Stimulus functions of drugs and the assessmet of abuse liability. Drug Res Dev 20:231–249

    Google Scholar 

  • Caccia S, Ballabio M, Samanin R, Zanini MG, Gavattini S (1981) (-)mCPP, a central 5-hydroxytrypatamine agonist, is a metabolite of trazadone. J Pharm Pharmacol 33:477–478

    Google Scholar 

  • Caccia S, Fung MH, Gavattini S, Zanini MG (1982) Plasma concentrations of trazadone and 1-(3-chlorophenyl)piperazine in man after a single oral dose of trazadone. J Pharm Pharmacol 34:605–606

    Google Scholar 

  • Callahan PM, Cunningham KA (1994) Involvement of 5-HT2C receptors in mediating the discriminative stimulus properties ofm-chlorophenylpiperazine (mCPP) Eur J Pharmacol 257:27–38

    Google Scholar 

  • Canton H, Laurence V, Colpaert FC (1990) Binding of typical and atypical antipsychotics to 5-HT1C and 5-HT2 sites: clozapine potently interacts with 5-HT1C sites. Eur J Pharm 191:93–96

    Google Scholar 

  • Carver JG, Grahame-Smith DG, Johnson ES, Madgwick Z (1992) The effects of 5-HT andm-chlorophenylpiperazine (mCPP) on the efflux of [3H]5-HT from human perfused platelets. Br J Clin Pharmacol 35:473–478

    Google Scholar 

  • Charney PS, Woods SW, Goodman WK, Heninger GR (1987) Serotonin function in anxiety II: Effects of the serotonin agonist mCPP in panic disorder patients and healthy subjects. Psychopharmacology 92:14–24

    Google Scholar 

  • Cohen ML, Fuller RW (1983) Antagonism of vascular serotonin receptors by m-chlorophenylpiperazine andm-trifluoromethylphenylpiperazine. Life Sci 32:711–718

    Google Scholar 

  • Colpaert FC (1990) Drug discrimination: methods of manipulation, measurement and analysis. In: Bozarth MA (ed) Methods of assessing the reinforcing properties of abused drugs. Springer, Berlin pp 341–372

    Google Scholar 

  • Conn PJ, Sanders-Bush E (1985) Serotonin stimulated phosphoinositide turnover: mediation by the S2 binding site in rat cerebral cortex, but not subcortical regions. J Pharmacol Exp Ther 234:195–203

    Google Scholar 

  • Conn PJ, Sanders-Bush E (1986) Agonist-induced phosphoinositide hydrolysis in rat choroid plexus. J Neurochem 47:1754–1769

    Google Scholar 

  • Conn PJ, Sanders-Bush E (1987) Relative efficacies of piperazines at the phosphoinositide hydrolysis-linked serotonergic 5-HT1C and 5-HT2 receptors. J Pharmacol Exp Ther 242:552–557

    Google Scholar 

  • Friedman RL, Barrett RJ, Sanders-Bush E (1984) Discriminative stimulus properties of quipazine: mediation by serotonin2 binding sites. J Pharmacol Exp Ther 228:628–634

    Google Scholar 

  • Fuller RW, Snoddy HD, Mason MR, Owens JE (1981) Disposition and pharmacological effects ofm-chlorophenylpiperazine in rats. Neuropharmacology 20:155–162

    Google Scholar 

  • Glennon RA, Rosecrans JA, Young R (1982) The use of the drug discrimination paradigm for studying hallucinogenic agents. In: Colpaert FC, Slangen JL (eds) Drug discrimination: applications in CNS pharmacology. Elsevier Biomedical Press, Amsterdam, pp 69–96

    Google Scholar 

  • Glennon RA, Rosecrans JA, Young R (1984) Drug-induced discrimination: a description of the paradigm and a review of its specific application to the study of hallucinogenic agents. Med Res Rev 3:289–376

    Google Scholar 

  • Hamick A, Peroutka SJ (1989) 1-(m-Chloro-phenyl)piperazine interactions with neurotransmitters in the human brain. Biol Psychiatry 25:569–575

    Google Scholar 

  • Hoenicke EM, Vanacek SA, Woods JH (1992) The discriminative stimulus effects of clozapine in pigeons: involvement of 5-HT1C and 5-HT2 receptors. J Pharmacol Exp Ther 263:276–284

    Google Scholar 

  • Hollander E, Decaria C, Gully R (1991) Effects of chronic fluoxetine treatment on behavioral and neuroendocrine responses tom-chlorophenylpiperazine in obsessive-compulsive disorder. Psychiatry Res 36:1–17

    Google Scholar 

  • Hoyer D (1988) Functional correlates of serotonin 5-HT1recognition sites. J Recept Res 8:59–81

    Google Scholar 

  • Hoyer D, Waeber C, Schoeffter P, Palacios JM, Dravid A (1989) 5-HT1C receptor mediated stimulation of inositol phosphate production in pig choroid plexus. Naunyn-Schmiedeberg's Arch Pharmacol 339:225–238

    Google Scholar 

  • Hoyer D, Schoeffter P, Sahin-Erdemli I (1991) Competitive antagonism by recognized 5-HT2 receptor antagonists at 5-HT1C receptors in pig choroid plexus. Naunyn-Schmiedeberg's Arch Pharmacol 344:137–142

    Google Scholar 

  • Hoyer D, Clarke DE, Fozard JR, Hartig PR, Martin GR, Mylecharane EJ, Saxena PR, Humphrey PA (1994) International union of pharmacology classification of receptors for 5-hydroxytryptamine (serotonin). Pharmacol Rev 46:157–203

    Google Scholar 

  • Hulihan-Giblin BA, Park YD, Goldman D, Aulakh CS (1993) Analysis of the 5-HT1C receptor and the serotonin uptake site in Fawn-Hooded rat brain. Eur J Pharmacol 239:99–102

    Google Scholar 

  • Iqbal N, Asnis GM, Wetzler S, Kahn RS, Van Praag HM (1991) The mCPP challenge test in schizophrenia: humoral and behavioral responses. Biol Psychiatry 30:770–778

    Google Scholar 

  • Johnson RG, Fiorella D, Rabin RA (1993) Effects of chronic cocaine administration on the serotonergic system in rat brain. Pharmacol Biochem Behav 46:289–293

    Google Scholar 

  • Julius DJ, Macdermott AB, Axel R, Jessell JM (1988) Molecular characterization of a functional cDNA encoding the serotonin1C receptor. Science 241:558–564

    Google Scholar 

  • Kahn RS, Wetzler S (1991)m-Chlorophenylpiperazine as a probe of serotonin function. Biol Psychiatry 30:1139–1166

    Google Scholar 

  • Kahn RS, Wetzler S, Van Praag, Asnis GM, Strauman T (1988) Behavioral indications for serotonin receptor hypersensitivity in panic disorder. Psychiatry Res 25:101–104

    Google Scholar 

  • Kahn RS, Kalus O, Cahn W, Wetzler S, Asnis GM, Van Praag HM (1990) The effect of 5-HT antagonists onm-chlorophenylpiperazine mediated responses. Psychiatry Res 33:189–198

    Google Scholar 

  • Kalus O, Kahn RS, Wetzler S, Asnis GM, Van Praag HM (1991) Behavioral hypersensitivity tom-chlorophenylpiperazine in a subject with subclinical panic attacks. Biol Psychiatry 28:1053–1057

    Google Scholar 

  • Kennett GA, Curzon G (1988) Evidence that mCPP may have behavioral effects mediated by central 5-HT1C receptors. Br J Pharmacol 94:137–147

    Google Scholar 

  • Kennett GA, Curzon G (1991) Potencies of antagonists indicate that 5-HT1C receptors mediate 1-3(chlorophenyl)piperazine induced hypophagia. Br J Pharmacol 103:2016–2020

    Google Scholar 

  • Krystal JH, Seibyl JP, Lawrence HP, Woods SW, Heninger GR, Aghajanian GK, Charney DS (1993)m-Chlorophenylpiperazine effects in neuroleptic free schizophrenic patients. Arch Gen Psychiatry 50:624–635

    Google Scholar 

  • Lucki I, Ward HR, Frazer A (1989) Effect of 1-(m-chlorophenyl) piperazine and 1-(m-trifluoromethylphenyl)piperazine on locomotor activity. JPharmacol Exp Ther 249:155–164

    Google Scholar 

  • Murphy DL, Lesch KP, Aulakh CS, Pigott TA (1991) Serotoninselective arylpiperazines with neuroendocrine, temperature, and cardiovascular effects in humans. Pharmacol Rev 43:527–552

    Google Scholar 

  • Nelson DL, Herbert A, Bergoin G, Glowinski J, Haman M (1978) Characteristics of central 5-HT receptors and their adaptive changes following intracerebral 5,7-dihydroxytryptamine administration in the rat. Mol Pharmacol 14:983–995

    Google Scholar 

  • Prichett DB, Bach AW, Wozny M, Talab O, Taso RD, Shih JC, Seeberg PH (1988) Structure and functional expression of the cloned rat serotonin 5-HT1C receptors in choroid plexus. EMBO J 7:4135–4140

    Google Scholar 

  • Sanders-Bush E, Breeding M (1988) Putative selective 5-HT2antagonists block serotonin 5-HT1C receptors in choroid plexus. J Pharmacol Exp Ther 247:169–173

    Google Scholar 

  • Sanders-Bush E, Conn PJ (1988) LSD and 2,5-dimethoxy-4-methylamphetamine are partial agonists at serotonin receptors linked to PI hydrolysis. J Pharmacol Exp Ther 246:924–928

    Google Scholar 

  • Van Wijngaarden I, Tulp M Th M, Soudijn W (1990) The concept of selectivity in 5-HT research. Eur J Pharmacol 179:357–366

    Google Scholar 

  • Winter JC (1978) Drug-induced stimulus control. In: Blackman D, Sanger J (eds) Contemporary research in behavioral pharmacology. Plenum Press, N.Y., pp 341–372

    Google Scholar 

  • Winter JC (1994) The stimulus effects of serotonergic hallucinogens in animals. In: Lin GC (ed) Hallucinogens, an update. NIDA Monograph, US Government Printing Office 146:157–182

  • Winter JC, Rabin RA (1993) Discriminative stimulus properties ofm-chloropiperazine. Pharmacol Biochem Behav 45:221–223

    Google Scholar 

  • Zohar J, Meuller EA, Insel TR, Zohar-Kadouch RC, Murphy DL (1987) Serotonergic responsivity in obsessive-compulsive disorder: comparison of patients and healthy controls. Arch Gen Psychiatry 44:946–951

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pharmacology and Toxicology, School of Medicine and Biomedical Sciences, State University of New York at Buffalo, Buffalo, New York, USA

    D. Fiorella, R. A. Rabin & J. C. Winter

Authors
  1. D. Fiorella
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. R. A. Rabin
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. J. C. Winter
    View author publications

    You can also search for this author in PubMed Google Scholar

Additional information

This study was supported in part by U.S. Public Health Service grant DA 03385 (J.C.W., R.A.R.), by National Research Service Award MH 10567 (D.F.), and by a fellowship from Schering-Plough Research Institute (D.F.). Animals used in these studies were maintained in accordance with the “Guide for Care and Use of Laboratory Animals” of the Institute of Laboratory Animal Resources, National Research Council.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Fiorella, D., Rabin, R.A. & Winter, J.C. The role of the 5-HT2A and 5-HT2C receptors in the stimulus effects ofm-chlorophenylpiperazine. Psychopharmacology 119, 222–230 (1995). https://doi.org/10.1007/BF02246164

Download citation

  • Received:

  • Revised:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02246164

Key words

Search

Navigation